Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02931240 · ClinicalTrials.gov registry record · NA
BioVentrix Revivent TC™ System Clinical Study
A NA study of Ventricular Dysfunction, Left, sponsored by BioVentrix.
- Active
- Registry status
- NA
- Development phase
- 126
- Enrollment target
- 20
- Study locations
NCT02931240 is a NA study of Ventricular Dysfunction, Left that is active but no longer recruiting, run by BioVentrix. The registered enrollment target is 126 participants. The trial reports 20 study locations across 15 states.
The verdict
NCT02931240, a NA study of Ventricular Dysfunction, Left, is active but no longer recruiting, sponsored by BioVentrix.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
- 20
- Study locations
Study Summary
A prospective, multi-center, dual-arm pivotal study of the BioVentrix Revivent TC System, with 2:1 study vs. active concurrent control group allocation ratio. This study will include 126 patients of which 84 patients will be treated with the investigational device and 42 patients will be included in an active control group.
Conditions Studied
Interventions
- DEVICE Revivent TC
Study Locations (20)
California
- Ronald Regan UCLA Medical Center - Los Angeles
- University of California, San Francisco - San Francisco
- Los Robles Hospital & Medical Center - Thousand Oaks
Georgia
- Emory University Hospital Midtown - Atlanta
- WellStar Health System - Marietta
New York
- Mount Sinai Hospital - New York
- New York Presbyterian Hospital - New York
Pennsylvania
- UPMC Pinnacle - Harrisburg
- Penn State Health Milton S. Hershey Medical Center - Hershey
Arizona
- University of Arizona College of Medicine - Phoenix Banner University Medicine Heart Institute - Phoenix
Florida
- Baptist Hospital of Maimi - Miami
Illinois
- Memorial Medical Center - Springfield
Louisiana
- Terrebonne General Medical Center - Houma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2017-08-29 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02931240
The ClinicalTrials.gov registry entry for NCT02931240 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioVentrix, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ventricular Dysfunction, Left appearing as the primary indexed condition, and to 1 intervention - of which Revivent TC is the first listed.
NCT02931240 reports 20 study locations spanning 15 distinct geographic areas - top geographies include California, Georgia, New York.
Frequently Asked Questions
What is clinical trial NCT02931240 about?
NCT02931240 is a clinical study titled "BioVentrix Revivent TC™ System Clinical Study". A prospective, multi-center, dual-arm pivotal study of the BioVentrix Revivent TC System, with 2:1 study vs. active concurrent control group allocation ratio. This study will include 126 patients of which 84 patients will be treated with the investigational device and 42 patients will be included in...
What is the current status of trial NCT02931240?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 126 participants. The study started on 2017-08-29. Estimated completion is 2027-06-30.
What conditions does trial NCT02931240 study?
This clinical trial studies the following conditions: Ventricular Dysfunction, Left.
What interventions are being tested in trial NCT02931240?
The interventions under investigation include: Revivent TC (DEVICE).
Who is sponsoring clinical trial NCT02931240?
This trial is sponsored by BioVentrix, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02931240 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventricular Dysfunction, Left
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.